Randomized, Double-blind Safety and Efficacy Study of Lisdexamfetamine Dimesylate (LDX) in Children and Adolescents Aged 6-17
Clinical trial NCT00763971 · COMPLETED
Trial details
- NCT number
- NCT00763971
- Sponsor
- Shire
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-17
- Primary completion
- 2011-03-16
- Enrollment
- 336
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.